- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 1, 2025 | 45.78M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $186.83M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $253.64M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $280.03M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $220.71M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $204.84M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $340.43M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $331.07M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $710.6M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $832.81M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $2.04B |
| Total Assets | Q2 2025 · Sep 30, 2024 | $2.1B |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 55.44M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 56.08M sh |
| Capex restated | Q2 2025 · Mar 31, 2024 | $19.54M |
| Operating Cash Flow restated | Q2 2025 · Mar 31, 2024 | $22.37M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $2.22B |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $2.44B |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $2.53B |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$2.47 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$2.72 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$2.47 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$2.72 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $69.06M |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $138.95M |
| Rd Expense restated | Q2 2025 · Mar 31, 2024 | $7.73M |
| Rd Expense restated | Q2 2025 · Mar 31, 2024 | $15.05M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$136.88M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$152.6M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$24.21M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$40.46M |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $60.66M |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $122.41M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $136.36M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $278.08M |